Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Remke

Showing results (61-70 of 184) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Molecular staging of intracranial ependymoma in children and adultsAndrey Korshunov, Hendrik Witt, Thomas Hielscher, et al.
Developmental Cell|June 25, 2014
Shh signaling protects Atoh1 from degradation mediated by the E3 ubiquitin ligase Huwe1 in neural precursorsAntoine Forget, Laure Bihannic, Sara Maria Cigna, et al.
Journal of Medicinal Chemistry|June 6, 2017
Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell LinesKatharina Stenzel, Alexandra Hamacher, Finn K Hansen, et al.
Journal of Neuro-Oncology|November 17, 2023
The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastomaNan Qin, Eunice Paisana, Daniel Picard, et al.
Cell Death Discovery|April 5, 2022
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastomaKai Voeltzke, Katerina Scharov, Cornelius Maximilian Funk, et al.
Cell Death and Differentiation|June 3, 2017
MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivationAlberto Delaidelli, Gian Luca Negri, Asad Jan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2013
Sleeping Beauty mutagenesis in a mouse medulloblastoma model defines networks that discriminate between human molecular subgroupsLaura A Genovesi, Ching Ging Ng, Melissa J Davis, et al.
The Journal of Clinical Investigation|March 16, 2011
An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in miceJan Gronych, Andrey Korshunov, Josephine Bageritz, et al.
International Journal of Cancer|May 14, 2019
The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cellsMor Varon, Tal Levy, Gal Mazor, et al.
Molecular Cancer|August 15, 2023
Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumorsPaweł Stachura, Wei Liu, Haifeng C Xu, et al.
Pageof 19

Showing results (61-70 of 184) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Molecular staging of intracranial ependymoma in children and adultsAndrey Korshunov, Hendrik Witt, Thomas Hielscher, et al.
Developmental Cell|June 25, 2014
Shh signaling protects Atoh1 from degradation mediated by the E3 ubiquitin ligase Huwe1 in neural precursorsAntoine Forget, Laure Bihannic, Sara Maria Cigna, et al.
Journal of Medicinal Chemistry|June 6, 2017
Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell LinesKatharina Stenzel, Alexandra Hamacher, Finn K Hansen, et al.
Journal of Neuro-Oncology|November 17, 2023
The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastomaNan Qin, Eunice Paisana, Daniel Picard, et al.
Cell Death Discovery|April 5, 2022
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastomaKai Voeltzke, Katerina Scharov, Cornelius Maximilian Funk, et al.
Cell Death and Differentiation|June 3, 2017
MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivationAlberto Delaidelli, Gian Luca Negri, Asad Jan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2013
Sleeping Beauty mutagenesis in a mouse medulloblastoma model defines networks that discriminate between human molecular subgroupsLaura A Genovesi, Ching Ging Ng, Melissa J Davis, et al.
The Journal of Clinical Investigation|March 16, 2011
An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in miceJan Gronych, Andrey Korshunov, Josephine Bageritz, et al.
International Journal of Cancer|May 14, 2019
The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cellsMor Varon, Tal Levy, Gal Mazor, et al.
Molecular Cancer|August 15, 2023
Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumorsPaweł Stachura, Wei Liu, Haifeng C Xu, et al.
Pageof 19